PHARMACEUTICAL COMPOSITION AND ITS USE FOR THE PREVENTION AND TREATMENT OF ORAL CAVITY PATHOLOGIES
申请人:Grossi, Lionello
公开号:EP3656370A1
公开(公告)日:2020-05-27
The invention relates to a pharmaceutical composition comprising lysozyme, dextranase and an essential oil of a plant belonging to the family Myrtaceae for the prevention, treatment and follow-up of pathologies of the oral cavity of infectious, inflammatory, degenerative or autoimmune origin, preferably selected in the group consisting of: gingivitis, periodontitis, aphthous stomatitis, herpetic stomatitis, prosthetic stomatitis, recurrent aphthosis, xerostomia, xerostomia due to Sjögren's syndrome, burning mouth syndrome (BMS), oral candidiasis, inflammatory dermatoses such as oral lichen planus, autoimmune disorders of the mucous membranes such as mucous membrane pemphigoid (MMP), graft-versus-host disease, white tongue, migratory glossitis, desquamative gingivitis due to oral lichen planus, herpes and combinations thereof.
The composition is preferably formulated, together with other ingredients, as a mouthwash for oral rinses.
本发明涉及一种药物组合物,该组合物由溶菌酶、
葡聚糖酶和一种桃
金娘科植物的精油组成,用于预防、治疗和跟踪口腔感染性、炎症性、退行性或自身免疫性病变,这些病变最好选自以下组别:牙龈炎、牙周炎、口腔炎、疱疹性口腔炎、修复性口腔炎、复发性口臭、口腔干燥症、斯约格伦综合征引起的口腔干燥症、灼热口腔综合征(BMS)、口腔念珠菌病、炎症性皮肤病,如口腔扁平苔藓、粘膜自身免疫性疾病,如粘膜丘疹(MMP)、移植物抗宿主病、白舌、移行性舌炎、口腔扁平苔藓引起的脱屑性牙龈炎、疱疹及其组合。
该组合物最好与其他成分一起配制成漱口
水,用于口腔冲洗。